Distinct Inactivated Bacterial-Based Immune Modulators Vary in Their Therapeutic Efficacies for Treating Disease Based on the Organ Site of Pathology

Scientific Reports - United Kingdom
doi 10.1038/s41598-020-62735-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Auto-Immune Disease: II. Pathology of the Immune Response

BMJ
1959English

Bacterial Immune Evasion Proteins: The Therapeutic Potential of CHIPS

2020English

Metastatic Colorectal Cancer: Therapeutic Options for Treating Refractory Disease

Current Oncology
Oncology
2019English

Lupus-Prone Strains Vary in Susceptibility to Antibody-Mediated End Organ Disease

Genes and Immunity
ImmunologyGenetics
2013English

Metformin: A Therapeutic Option for Treating Nonalcoholic Fatty Liver Disease

Digestive Diseases and Sciences
PhysiologyGastroenterology
2010English

The Prodrug of 7,8-Dihydroxyflavone Development and Therapeutic Efficacy for Treating Alzheimer’s Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2018English

Simple Architecture for Subsampling LC-based Modulators

Electronics Letters
Electronic EngineeringElectrical
2010English

Glutamatergic Modulators: The Future of Treating Mood Disorders?

Harvard Review of Psychiatry
PsychiatryMental Health
2010English

Advance in Physiologically Based Pharmacokinetic Modelling: From the Organ Level to Sub-Organ Level Based on Experimental Data

Journal of Physiology
PhysiologySports Science
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy